Will the Millennials Actually Live to Be 100?

Will humans someday live to be 100? Is it now possible that the new normal life expectancy for individuals will be 100 or even 150 years?

Some have argued that advances in biomedical science and drug therapy, have made this dream a reality; others, are more skeptical and view these claims as unfounded.

Living past the age of 100 may not be as fantastical an event as many people today may think.

According to Steven N. Austad, a biologist at the University of Alabama at Birmingham, by the year 2150, advances in biomedical science and pharmaceuticals that improve cellular function, “would make living to 100 routine, with a few people reaching the age of 150 years — somewhat like people routinely live to age 80 today with a few people living to 110.”

The key for achieving this substantial leap in life expectancies will come from focusing on the aging process itself. Aging is the most significant factor in nearly everything that kills humans today.

Most people at the later stages of their lives die from diseases, whether that is cancer, diabetes, heart disease or dementia. Realizing the goal of extending life expectancies, according to scientists, such as Austad, lies in our new ability to prevent those specific diseases that afflict us later in life.

Crossover benefits

At the end of last century, there began to emerge a novel approach to good health that focused on the underlying aging process, rather than addressing the onset of the diseases themselves as people grow older. Researchers found that by using drugs, modifying diets and altering genes, treating aging was not difficult.

These protocols worked in mice, that, like humans, are mammals. Mice share 98% of the gene structure as humans.

Treating aging has broad benefits and scientists have discovered that curing one affliction with drug therapy has cross-over benefits in curing other non-related diseases.

For example, one drug called rapamycin made mice live considerably longer. This same drug delayed the onset of some cancers and eradicated others; additionally, it delayed the mouse equivalent of Alzheimer’s as well as heart aging.

The most surprising finding with the drug intervention trials was that rapamycin was found to have the identical health benefits, whether treatment was started early in mice’s early lives or much later.

Another drug, metformin, used for treating diabetes, showed similar promise as that of rapamycin, for slowing the diseases associated with aging. Moreover, metformin, surprisingly, has shown more promise in humans.

Scientists compared people taking metformin for diabetes with people not taking the drug, or taking a different diabetes drug, and compared the rates of cancer, heart disease and dementia in those groups.

The research revealed less-frequent incidences of these illnesses in the control groups taking metformin than in the groups not taking metformin.

Based on the promising results of trial drug intervention therapies, Austad contends that advances in life expectancy can occur if we accept the idea that diseases related to aging have many and extensive overlapping causes.

Marginal increases

Not all scientists subscribe to the view that advances in pharmacological intervention, genetic alterations or diet modifications, can extend life expectancies much beyond the current average old-age mortality rates.

Jay Olshansky, a professor of epidemiology and biostatistics in the School of Public Health at the University of Illinois at Chicago, believes that while “many more people will live to see 100,” life expectancy rates will not climb much higher.

Olshansky argues that the idea of living well beyond 100 is inconsistent with the realities of math, science, statistics and the inherent design limitations of the human body. Even were it possible to treat age-related diseases individually, the process would yield diminishing gains in life expectancy the older we get.

One of the most difficult hurdles to surpass for raising the average life expectancy by quantum leaps, relative to today’s figures, is that life expectancy data cannot be viewed in isolation or individually. It is a population-wide measure.

In order for 100 to be the new life expectancy benchmark, the law of averages requires that a substantial proportion of the entire population must live past the current known human lifespan of 122, a feat that has been attained by only one individual.

That is an almost impossible goal to attain from a statistically significant large pool of subjects.

In terms of the promising enhanced life expectancies observed by using drug therapy treatments in mice, Olshansky says that humans don’t experience biological time in the same manner as mice.

Doubling the life expectancy of a short-lived species, such as mice, likely will result in only a small fraction of the increase or gain in humans. For example, doubling the lifespan of a mouse from three years to six years doesn’t necessarily mean an individual’s life expectancy will double from 80 to 160 years.

Skeptics of the idea that human life expectancy can be radically increased over current old-age mortality rates, argue that aging isn’t a “disease,” any more than other aspects that affect our bodies such as puberty and physical growth.

The final argument against the “100 will be the new normal” thesis is that humans, as currently physically constituted, are no more capable of living to 100 as a population group than most individuals can be expected to dunk a basketball, or run a sub-four-minute mile. 

Yet we keep trying.

Recommended Articles

Before You Sign, Read the Pros and Cons of Timeshares

Timeshares are upscale vacation and recreational properties that are simultaneously owned by multiple investors. However, there is a catch. Each owner is contractually obligated to only visit and inhabit the

6 Fast-Food Facts That Will Make You Put Down That Burger

Americans are more overweight than ever before. Sedentary lifestyles and poor diet is to blame. The convenience of fast food is also a factor. Morbid obesity increases the potential for

7 Common Impulse Purchases People Regret the Most

The bane of consumerism is that people voluntarily buy things that they don’t need or want for its own sake. By some estimates nearly 80% of American consumers buy some

10 Detoxifying, Filling Foods to Help You Slim Down Without Deprivation

Fad diets are a trend that may never die, as much as most of us want them to. It’s high time we took the focus off skinny and turned to

6 Ways to Get Perfectly Legit Free Government Cash

No such thing as a free lunch. Well, as a rule, yes. But we also know that for every rule, there are exceptions. While on one hand, we must beware

A Healthier You In Just a Month With These 12 New Habits

This is a simple guide to creating a healthier you in just one month! Some of these may be difficult, but the end results of feeling great are well worth

Warren Buffett’s Partner Says the Secret Is ‘Just Avoid Being Stupid’

Avoid meetings and read constantly, advises 95-year-old Charlie Munger If you avoid doing stupid things, it's easy to make money investing, he says. Disciple of value investing godfather Benjamin Graham

Wills, Trusts, and Living Trusts: Which Do You Need?

Regardless of your overall net worth, you should have a plan in place to make sure your financial affairs are in order before passing on. There is nothing more frustrating

6 Hugely Successful Businesses Started On a Shoestring Budget

You really need money to launch a business, but not as much as you’d think. What you need to start a business is a strategic business plan and an idea

How to Grow Your Own Never-Ending Supply of Ginger Indoors

Ginger is the ideal plant to grow inside your home. Growing ginger requires little sunlight and maintenance, which makes it simple and convenient for you! Plus you get an endless supply

4 Ways to Generate Extra Income Today

Feel dissatisfied with what you are earning from your day job? Think you have the potential to earn more? Well, the first thing to remember is that there are no

Should You Buy That Hot IPO? The Data Says Proceed with Caution

IPOs are hot, until they're not. Many trade lower after going public. It's important to understand how, and if, a company can become profitable. Who benefits from an IPO? In